Breaking News Instant updates and real-time market news.

MON

Monsanto

$117.96

0.1 (0.08%)

, BAYRY

Bayer

$28.65

-0.12 (-0.42%)

13:52
04/09/18
04/09
13:52
04/09/18
13:52

DOJ to allow Bayer acquisition of Monsanto after concessions, WSJ reports

MON

Monsanto

$117.96

0.1 (0.08%)

BAYRY

Bayer

$28.65

-0.12 (-0.42%)

  • 14

    Apr

  • 08

    May

  • 18

    May

MON Monsanto
$117.96

0.1 (0.08%)

07/12/17
07/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Monsanto (MON) downgraded to Hold from Buy at Jefferies with analyst Laurence Alexander saying Bayer's (BAYRY) all-cash offer appears on track for year-end. The analyst views the deal failing as a "low-probability scenario" and keeps a $128 price target for the shares. 2. Freeport McMoRan (FCX) downgraded to Sell from Hold at Berenberg. 3. Kimberly-Clark (KMB) downgraded to Sell from Neutral at UBS with analyst Stephen Powers saying the stock's 11% rise year-to-date is not based on fundamentals but news flow of consolidation in the Household Products sector. 4. Harley-Davidson (HOG) downgraded to Market Perform from Outperform at Bernstein with analyst David Beckel citing his belief that "demographic shifts and a stagnating economy" will prevent demand for the company's motorcycles from growing in the U.S. for the next five years. 5. IMAX (IMAX) downgraded to Market Perform from Outperform at Barrington with analyst James Goss saying positive catalysts "might take some time to develop." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/18/17
UBSW
08/18/17
DOWNGRADE
Target $128
UBSW
Neutral
Monsanto downgraded to Neutral from Buy at UBS
UBS analyst John Roberts downgraded Monsanto (MON) to Neutral saying the shares are now less than 10% away from the accepted Bayer (BAYRY) offer of $128. The analyst calculates that the market is currently pricing in a 70% chance of the deal going through. His view that the deal could be approved remains unchanged. Approvals of peer deals suggest antitrust approval likely for Monsanto, Roberts tells investors in a research note. The analyst keeps a $128 price target for Monsanto shares.
09/05/17
BERN
09/05/17
NO CHANGE
BERN
Bernstein still sees 'very high' probability of Bayer, Monsanto deal approval
Bernstein analyst Jeremy Redenius notes that the European Commission has opened an in-depth review of the Bayer (BAYRY)/Monsanto (MON) deal due to concerns of reduced competition in pesticides, seeds, and traits. The analyst believes this is not surprising, as the in-depth review is the norm for deals of this size. Comparing the EC's initial concerns with those of the Dow/DuPont (DWDP) deal, he still sees a "very high" probability of deal approval.
10/04/17
MACQ
10/04/17
DOWNGRADE
MACQ
Neutral
Monsanto downgraded to Neutral from Outperform at Macquarie
BAYRY Bayer
$28.65

-0.12 (-0.42%)

11/15/17
MSCO
11/15/17
NO CHANGE
Target $103
MSCO
Overweight
Loxo Oncology partnership with Bayer better than recognized, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison thinks Loxo Oncology's (LOXO) partnership with Bayer (BAYRY) is a smart move and points to two key aspects of the deal that are being underappreciated. Namely, the deal offsets the risk of a slow TRK launch while he also believes strategic optionality is still intact as Loxo maintains two fully owned program, Harrison tells investors. Harrison maintains an Overweight rating on Loxo with a $103 price target. The stock slid about 4% yesterday to close at $79.84 after the Bayer deal was announced.
11/16/17
JEFF
11/16/17
NO CHANGE
JEFF
Buy
Jefferies names Roche new top global pick in Pharmaceuticals
Jefferies analyst Jeffrey Holford names Roche (RHHBY) his new "Top Pick Globally" in Pharmaceuticals following the strong share performance of his previous top pick for 2017, AbbVie (ABBV). The analyst believes the company's growth outlook is better than many investors think. Roche is nearing sentiment lows and investors "need to look hard at the replacement power" offered by assets Tecentriq, Ocrevus, Gazyva, ACE910 and Perjeta, Holford tells investors in a research note. Following Roche, the analyst has the highest conviction on Novartis (NVS), Bayer (BAYRY), AbbVie, Johnson & Johnson (JNJ), Zoetis (ZTS) and Eli Lilly (LLY). His least preferred stocks in Pharmaceuticals are Merck (MRK), Novo Nordisk (NVO) and AstraZeneca (AZN).
12/28/17
ARGS
12/28/17
NO CHANGE
Target $470
ARGS
Buy
Regeneron price target lowered to $470 from $540 at Argus
Argus analyst Jasper Hellweg lowered his price target on Regeneron (REGN) to $470 to reflect some of the recent weakness in the stock, but keeps his Buy rating. Hellweg says that while the company's growth has slowed in recent years, it continues to benefit from sales of Eylea, collaboration agreements with Sanofi (SNY) and Bayer (BAYRY) as well as a strong new product pipeline.
12/29/17
JPMS
12/29/17
NO CHANGE
JPMS
Roche added to Analyst Focus List at JPMorgan
JPMorgan analyst Richard Vosser added Roche (RHHBY) to his firm's Analyst Focus List and keeps an Overweight rating on the shares with a SFR 300 price target. The analyst sees Roche as having the most significant earnings upside potential of any of the European large cap pharma stocks in 2018. He believes the potential of the company's pipeline is being underappreciated at current share levels. His top picks for 2018 are Roche and Bayer (BAYRY).

TODAY'S FREE FLY STORIES

HLX

Helix Energy

$7.05

0.81 (12.98%)

06:03
04/25/18
04/25
06:03
04/25/18
06:03
Upgrade
Helix Energy rating change  »

Helix Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ANTM

Anthem

$225.08

-2.11 (-0.93%)

06:03
04/25/18
04/25
06:03
04/25/18
06:03
Earnings
Anthem raises FY18 adjusted EPS view to greater than $15.30 per share »

Prior view was greater…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CVE

Cenovus Energy

$9.50

-0.1 (-1.04%)

06:03
04/25/18
04/25
06:03
04/25/18
06:03
Earnings
Breaking Earnings news story on Cenovus Energy »

Cenovus Energy reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

GRA

W.R. Grace

$66.25

-1.14 (-1.69%)

06:03
04/25/18
04/25
06:03
04/25/18
06:03
Earnings
W.R. Grace reports Q1 adjusted EPS 82c, consensus 73c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 17

    May

WST

West Pharmaceutical

$92.05

0.12 (0.13%)

06:01
04/25/18
04/25
06:01
04/25/18
06:01
Downgrade
West Pharmaceutical rating change  »

West Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

ANTM

Anthem

$225.08

-2.11 (-0.93%)

06:00
04/25/18
04/25
06:00
04/25/18
06:00
Earnings
Anthem reports Q1 adjusted EPS $5.41, consensus $4.91 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

05:50
04/25/18
04/25
05:50
04/25/18
05:50
General news
FX Action: USD-JPY corrected to a 108.98 low »

FX Action: USD-JPY…

CHKP

Check Point

$102.95

0.17 (0.17%)

05:38
04/25/18
04/25
05:38
04/25/18
05:38
Earnings
Check Point reports Q1 EPS $1.30, consensus $1.28 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

DISCA

Discovery

$23.94

0.17 (0.72%)

05:36
04/25/18
04/25
05:36
04/25/18
05:36
Hot Stocks
Discovery enters partnership with Digital Element »

Digital Element announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

SOGO

Sogou

$8.55

0.15 (1.79%)

05:35
04/25/18
04/25
05:35
04/25/18
05:35
Earnings
Breaking Earnings news story on Sogou »

Sogou sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOGO

Sogou

$8.55

0.15 (1.79%)

05:34
04/25/18
04/25
05:34
04/25/18
05:34
Earnings
Sogou reports Q1 EPS 5c, consensus 3c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CYOU

Changyou.com

$28.79

-0.9 (-3.03%)

05:32
04/25/18
04/25
05:32
04/25/18
05:32
Earnings
Changyou.com sees Q2 EPS 38c-47c, consensus 53c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CYOU

Changyou.com

$28.79

-0.9 (-3.03%)

05:30
04/25/18
04/25
05:30
04/25/18
05:30
Earnings
Changyou.com reports Q1 adj. EPS (30c), may not compare to consensus 53c »

Reports Q1 revenue $137M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOHU

Sohu.com

$30.26

-0.65 (-2.10%)

05:29
04/25/18
04/25
05:29
04/25/18
05:29
Earnings
Sohu.com sees Q2 EPS ($1.65)-($1.40), consensus ($1.32) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOHU

Sohu.com

$30.26

-0.65 (-2.10%)

05:28
04/25/18
04/25
05:28
04/25/18
05:28
Earnings
Breaking Earnings news story on Sohu.com »

Sohu.com reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SOHU

Sohu.com

$30.26

-0.65 (-2.10%)

05:26
04/25/18
04/25
05:26
04/25/18
05:26
Earnings
Sohu.com reports Q1 EPS ($2.39), consensus ($1.56) »

Reports Q1 revenue $455M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FOSL

Fossil

$14.21

-0.165 (-1.15%)

05:25
04/25/18
04/25
05:25
04/25/18
05:25
Hot Stocks
Fossil signs global license partnership with PUMA for watches, smartwatches »

Fossil Group and PUMA SE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$77.00

-0.595 (-0.77%)

05:23
04/25/18
04/25
05:23
04/25/18
05:23
Hot Stocks
Novartis announces launch of FocalView app »

Novartis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

  • 21

    May

  • 05

    Jun

EEFT

Euronet

$75.32

-1.04 (-1.36%)

05:22
04/25/18
04/25
05:22
04/25/18
05:22
Earnings
Breaking Earnings news story on Euronet »

Euronet sees Q2 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

EEFT

Euronet

$75.32

-1.04 (-1.36%)

05:21
04/25/18
04/25
05:21
04/25/18
05:21
Earnings
Euronet reports Q1 adj. EPS 73c, consensus 73c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ILMN

Illumina

$238.65

-7.19 (-2.92%)

05:02
04/25/18
04/25
05:02
04/25/18
05:02
Recommendations
Illumina analyst commentary  »

Illumina target upped to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 24

    May

  • 12

    Jun

PPG

PPG

$105.74

-3.12 (-2.87%)

04:56
04/25/18
04/25
04:56
04/25/18
04:56
Upgrade
PPG rating change  »

PPG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$151.02

-2.07 (-1.35%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Accenture to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AKAM

Akamai

$70.95

-0.73 (-1.02%)

, MRK

Merck

$60.08

-0.16 (-0.27%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Boardroom Resources to hold a summit »

2018 Boardroom Summit…

AKAM

Akamai

$70.95

-0.73 (-1.02%)

MRK

Merck

$60.08

-0.16 (-0.27%)

JNJ

Johnson & Johnson

$126.18

-0.65 (-0.51%)

LPLA

LPL Financial

$61.04

-0.5 (-0.81%)

GHC

Global Consumer Acquisition Corporation

$611.35

-4.65 (-0.75%)

FUN

Cedar Fair

$63.63

-0.44 (-0.69%)

DECK

Deckers Brands

$90.83

1.13 (1.26%)

CPB

Campbell Soup

$41.08

0.25 (0.61%)

BURBY

Burberry

AWK

American Water

$84.79

0.5 (0.59%)

BLK

BlackRock

$514.01

-5.79 (-1.11%)

STT

State Street

$101.07

-1.28 (-1.25%)

EA

Electronic Arts

$118.56

-0.99 (-0.83%)

HSY

Hershey

$92.81

-0.33 (-0.35%)

EQR

Equity Residential

$60.62

0.21 (0.35%)

APOG

Apogee Enterprises

$41.55

-1.11 (-2.60%)

VMC

Vulcan Materials

$111.32

-2.53 (-2.22%)

WEN

Wendy's

$16.84

-0.385 (-2.24%)

TWX

Time Warner

$96.02

-0.32 (-0.33%)

AMGN

Amgen

$171.91

-2.75 (-1.57%)

AGN

Allergan

$156.91

-2.98 (-1.86%)

CSCO

Cisco

$43.74

-0.49 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 03

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 15

    May

  • 17

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 12

    Jun

  • 14

    Jun

  • 23

    Oct

ANF

Abercrombie & Fitch

$27.03

0.265 (0.99%)

04:55
04/25/18
04/25
04:55
04/25/18
04:55
Conference/Events
Abercrombie & Fitch to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.